No Data
No Data
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3
Lake Street analyst Thomas Flaten maintains $Assertio(ASRT.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 44.1% and a
Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth
Assertio Therapeutics: A Strong Buy on Robust Financial Performance and Strategic Growth Potential